Plexus Corp. (NASDAQ:PLXS – Get Free Report) CEO Todd Kelsey sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $194.24, for a total transaction of $291,360.00. Following the completion of the sale, the chief executive officer owned 81,791 shares of the company’s stock, valued at $15,887,083.84. This trade represents a 1.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Plexus Trading Down 3.2%
Shares of PLXS opened at $195.00 on Friday. Plexus Corp. has a twelve month low of $103.43 and a twelve month high of $211.84. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $5.22 billion, a P/E ratio of 30.33 and a beta of 0.81. The firm’s 50-day moving average is $192.33 and its two-hundred day moving average is $162.11.
Plexus (NASDAQ:PLXS – Get Free Report) last announced its quarterly earnings results on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, topping the consensus estimate of $1.77 by $0.01. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.07 billion. During the same quarter in the previous year, the company earned $1.73 EPS. The company’s quarterly revenue was up 9.6% on a year-over-year basis. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, research analysts predict that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
PLXS has been the topic of a number of research reports. Williams Trading set a $195.00 price objective on shares of Plexus in a research note on Wednesday, January 28th. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 6th. Benchmark reaffirmed a “buy” rating and issued a $220.00 target price on shares of Plexus in a research note on Monday, March 16th. Stifel Nicolaus raised their price target on Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a research report on Friday, January 30th. Finally, Weiss Ratings upgraded Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, March 6th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $194.20.
Read Our Latest Research Report on Plexus
About Plexus
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Featured Stories
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
